Razny et al. demonstrated that the expression of Wnt pathway antagonists DKK, SOST, SFRPs, and WIF1 was significantly upregulated in obese individuals with T2DM and insulin resistance, while expression of β-catenin (a key factor of osteoblast formation) was significantly decreased [66]. The gene discussed is SOST; the disease is type 2 diabetes mellitus.